USBC (USBC) AI Stock Analysis

• Market Cap: $230.98M
• Dividend Yield: N/A
• Average Volume (3M): 608.13K
• Price to Earnings (P/E): ―
• Beta (1Y): 2.75
• Revenue Growth: N/A
• EPS Growth: 55.04%
• Country: US
• Employees: 12
• Sector: Technology
• Sector Strength: 88
• Industry: Hardware, Equipment & Parts
• EPS (TTM): -0.03
• Shares Outstanding: 388,143,680
• 10 Day Avg. Volume: 280,969
• 30 Day Avg. Volume: 608,129
• PEG Ratio: 0.04
• Price to Book (P/B): 0.87
• Price to Sales (P/S): 0.00
• P/FCF Ratio: -11.12
• Enterprise Value/Market Cap: 3.70
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: -5.67K
• Enterprise Value/Ebitda: -44.23
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 41 Neutral
• Price Target: $0.62 ▲(3.50% Upside)

The score is driven down primarily by very weak financial fundamentals (ongoing losses, negative cash flow, and sharply higher leverage) and bearish technical conditions (below key moving averages with negative MACD). Valuation offers limited support due to loss-making status and no dividend yield data, while the Bitcoin treasury agreement update is a modest positive but secondary.

Positive Factors

Innovative Technology

The company's patented Bio-RFID™ technology offers a unique, non-invasive solution for glucose monitoring, positioning it well in the growing medical diagnostics market.

Strategic Partnerships

Collaborations with established healthcare firms enhance market reach and integration of Know Labs' technology, potentially driving long-term revenue growth through licensing and sales.

R&D and Licensing Revenue

Diversified revenue through licensing and R&D partnerships supports financial stability and growth, leveraging Know Labs' proprietary technology across various applications.

Negative Factors

Financial Instability

The company's high leverage and negative equity suggest financial instability, which could limit its ability to invest in growth opportunities and sustain operations without external funding.

Negative Cash Flows

Persistent negative cash flows highlight liquidity issues, indicating that Know Labs may struggle to fund operations and growth without continued external financing.

Operational Inefficiencies

Negative profit margins and inconsistent revenue suggest operational inefficiencies, which could hinder Know Labs' ability to achieve profitability and sustainable growth.

USBC Business Overview & Revenue Model

Company Description

Know Labs, Inc. focuses on the development and commercialization of proprietary technologies in the United States. Its technology uses spectroscopy to direct electromagnetic energy through a substance or material to capture a molecular signature. The company refers to its technology as Bio-RFID. The Bio-RFID technology can be integrated into various wearable, mobile, or bench-top form factors. Its first application of Bio-RFID technology is a product marketed as a glucose monitor that provide the user with real time information on their blood glucose levels. The company was formerly known as Visualant, Incorporated and changed its name to Know Labs, Inc. in May 2018. Know Labs, Inc. was founded in 1998 and is headquartered in Seattle, Washington.

How the Company Makes Money

Know Labs makes money by developing and licensing its proprietary Bio-RFID™ technology. The company's revenue streams include technology licensing fees, partnerships with medical device manufacturers, and potential direct sales of its diagnostic devices. Significant partnerships with healthcare firms and medical technology companies contribute to its earnings by facilitating the integration of its technology into existing and new medical platforms. Additionally, Know Labs may generate revenue through collaborations for research and development, as well as through potential future regulatory approvals that could lead to broader market adoption.

USBC Financial Statement Overview

Summary

Financial performance is very weak: persistent and worsening net losses (to -$22.1M in 2025), consistently negative operating/free cash flow, and a sharp 2025 leverage increase (debt ~3.5x equity) that elevates solvency and refinancing risk.

Income Statement

Profitability is very weak and deteriorated: the company posted large losses every year shown, with net income falling from -$15.3M (2023) to -$16.6M (2024) and -$22.1M (2025). Revenue visibility is also poor—most years show $0 reported revenue (with only 2022 at ~$4.36M and 2020 at ~$0.12M), making margin quality and operating leverage difficult to support. A modest positive is that gross profit was positive in 2022 and 2023, but it has since turned negative again, reinforcing ongoing cost pressure and limited scale.

Balance Sheet

Leverage and capital structure risk are high. Total debt jumped dramatically to ~$342.8M in 2025 from ~$5.1M in 2024, while equity is comparatively small at ~$97.1M, leaving debt at ~3.5x equity. The balance sheet has also been unstable historically (including negative equity in 2020 and 2024), which typically signals accumulated losses and limited financial flexibility. Total assets in 2025 (~$125.1M) are well below total debt, highlighting refinancing and solvency risk if cash burn continues.

Cash Flow

Cash generation is consistently negative, with operating cash flow below zero in every year provided (about -$7.6M in 2025 vs. -$12.8M in 2024). Free cash flow is also negative each year and worsened sharply in 2025 (growth of roughly -192%), indicating an accelerating cash burn. While free cash flow tracks net losses closely (free cash flow is roughly in line with net income in magnitude), the key weakness is the absence of a path to self-funding operations.

Breakdown	TTM	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	0.00	0.00	0.00	0.00	4.36M	0.00
Gross Profit	-150.59K	-150.59K	-270.17K	274.02K	929.65K	-200.81K
EBITDA	-19.31M	-19.31M	-14.80M	-14.44M	-11.68M	-10.25M
Net Income	-22.12M	-22.12M	-16.58M	-15.29M	-20.07M	-25.36M
Balance Sheet
Total Assets	125.08M	125.08M	3.66M	8.27M	13.76M	12.89M
Cash, Cash Equivalents and Short-Term Investments	8.82M	8.82M	3.11M	8.02M	12.59M	12.26M
Total Debt	342.79M	342.79M	5.08M	2.92M	2.56M	9.91M
Total Liabilities	27.96M	27.96M	5.82M	4.52M	3.90M	11.65M
Stockholders Equity	97.12M	97.12M	-2.16M	3.74M	9.86M	1.24M
Cash Flow
Free Cash Flow	-7.60M	-7.60M	-12.90M	-10.43M	-7.78M	-7.15M
Operating Cash Flow	-7.60M	-7.60M	-12.83M	-10.35M	-6.92M	-6.85M
Investing Cash Flow	0.00	0.00	-66.35K	-80.80K	-855.47K	-299.52K
Financing Cash Flow	13.31M	13.31M	7.98M	5.86M	8.11M	15.11M

USBC Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 0.60
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For USBC, the sentiment is Negative. The current price of 0.6 is below the 20-day moving average (MA) of 0.65, below the 50-day MA of 0.73, and below the 200-day MA of 1.22, indicating a bearish trend. The MACD of -0.05 indicates Positive momentum. The RSI at 35.92 is Neutral, neither overbought nor oversold. The STOCH value of 20.11 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for USBC.

USBC Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	61 Neutral	$37.18B	12.37	-10.20%	1.83%	8.50%	-7.62%
KULR	59 Neutral	$184.98M	-6.15	-29.07%	―	71.92%	31.84%
LPTH	55 Neutral	$704.90M	―	-37.93%	―	36.85%	-77.93%
SATL	48 Neutral	$495.81M	-2.74	―	―	―	―
SLNH	46 Neutral	$167.58M	-0.23	-446.49%	―	-27.81%	26.81%
MVIS	44 Neutral	$288.60M	-2.48	-112.89%	―	-67.66%	13.39%
USBC	41 Neutral	$230.98M	-0.17	-46.59%	―	―	55.04%

USBC Corporate Events

USBC Updates Bitcoin Treasury Management Agreement with Hyrcanian

On December 12, 2025, USBC, Inc. amended and restated its Digital Asset Management Agreement with Hyrcanian Asset Management, LLC, which manages the company’s Bitcoin treasury strategy on a discretionary basis. The updated agreement clarifies and modernizes the terms governing how Hyrcanian oversees USBC’s Bitcoin holdings, signaling a continued and more clearly defined commitment to digital-asset-based treasury management that may affect how the company allocates and manages its corporate reserves.

USBC Announces Departure of Chief Operating Officer

On December 15, 2025, USBC, Inc. announced that its Chief Operating Officer, Mr. Kirk Chapman, departed from his role effective immediately, following a mutual agreement. Mr. Chapman played a key role in establishing the company’s early foundations, and the departure was noted to be amicable with no disagreements regarding the company’s operations, policies, or practices. USBC acknowledged Mr. Chapman’s contributions and extended well wishes for his future endeavors.

USBC Board Member John Cronin Resigns

On November 19, 2025, John Cronin resigned from the Board of Directors of USBC, Inc. His resignation was not due to any disagreements with the company’s operations, policies, or practices.